These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 36552961)

  • 1. Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis.
    Sun MY; Bhaskar SMM
    Diagnostics (Basel); 2022 Nov; 12(12):. PubMed ID: 36552961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence, risk factors, and prognostic value of venous thromboembolism in ovarian cancer patients receiving chemotherapy: a systematic review and meta-analysis.
    Ye L; Cai L; Fu Y; Zhuang D; Hu X; Jie Y
    World J Surg Oncol; 2021 Jan; 19(1):12. PubMed ID: 33441137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.
    Totaro M; Palazzi S; Castellini C; Parisi A; D'Amato F; Tienforti D; Baroni MG; Francavilla S; Barbonetti A
    Front Endocrinol (Lausanne); 2021; 12():741866. PubMed ID: 34880832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reporting Bias Leading to Discordant Venous Thromboembolism Rates in the United States Versus Non-US Countries Following Radical Cystectomy: A Systematic Review and Meta-analysis.
    Fantony JJ; Gopalakrishna A; Noord MV; Inman BA
    Eur Urol Focus; 2016 Jun; 2(2):189-196. PubMed ID: 28723534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporting Bias Leading to Discordant Venous Thromboembolism Rates in the United States Versus Non-US Countries Following Radical Cystectomy: A Systematic Review and Meta-analysis.
    Fantony JJ; Gopalakrishna A; Van Noord M; Inman BA
    Eur Urol Focus; 2016 Jun; 2(2):189-196. PubMed ID: 27430026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
    Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
    Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors for venous thromboembolism in patients with ovarian cancer during neoadjuvant chemotherapy: a meta-analysis.
    Han L; Chen Y; Zheng A; Chen H
    Am J Cancer Res; 2023; 13(5):2126-2134. PubMed ID: 37293158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial.
    Slagter AE; Sikorska K; Grootscholten C; van Laarhoven HWM; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; van de Velde CJH; van Grieken NCT; van Sandick JW; Jansen EPM; Verheij M; Cats A
    Cancer Med; 2020 Sep; 9(18):6609-6616. PubMed ID: 32735752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis.
    Xu Y; Jia Y; Zhang Q; Du Y; He Y; Zheng A
    Gynecol Oncol; 2021 Feb; 160(2):610-618. PubMed ID: 33221022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
    Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
    BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of venous thromboembolism in cancer patients receiving chemotherapy: a meta-analysis with systematic review.
    Bao Y; Wan X; Fu J; Wu B
    Ann Transl Med; 2021 Feb; 9(4):277. PubMed ID: 33708904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Venous Thromboembolism in Intensive Care Units: A Meta-Analysis.
    Gao X; Zeng L; Wang H; Zeng S; Tian J; Chen L; Peng T
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of venous thromboembolism associated with midline catheters compared with peripherally inserted central catheters: A systematic review and meta-analysis.
    Lu H; Yang Q; Yang L; Qu K; Tian B; Xiao Q; Xin X; Lv Y; Zheng X
    Nurs Open; 2022 May; 9(3):1873-1882. PubMed ID: 33991462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy.
    Fankhauser CD; Tran B; Pedregal M; Ruiz-Morales JM; Gonzalez-Billalabeitia E; Patrikidou A; Amir E; Seidel C; Bokemeyer C; Hermanns T; Rumyantsev A; Tryakin A; Brito M; Fléchon A; Kwan EM; Cheng T; Castellano D; Del Muro XG; Hamid AA; Ottaviano M; Palmieri G; Kitson R; Reid A; Heng DYC; Bedard PL; Sweeney CJ; Connors JM
    Eur Urol Focus; 2021 Sep; 7(5):1130-1136. PubMed ID: 33032968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Psoriasis With Incident Venous Thromboembolism and Peripheral Vascular Disease: A Systematic Review and Meta-analysis.
    Chen TL; Lee LL; Huang HK; Wang JH; Chen LY; Tsai HR; Loh CH; Chi CC
    JAMA Dermatol; 2022 Jan; 158(1):59-67. PubMed ID: 34851364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and incidence of arterial events in patients with venous thromboembolism compared to the general population: A systematic review and meta-analysis of cohort studies.
    Noumegni SR; Hoffmann C; Tromeur C; Lacut K; Didier R; Couturaud F; Bressollette L
    Thromb Res; 2021 Jul; 203():172-185. PubMed ID: 34029849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of venous thromboembolism among chemotherapy-treated patients with lung cancer and its association with mortality: a retrospective database study.
    Huang H; Korn JR; Mallick R; Friedman M; Nichols C; Menzin J
    J Thromb Thrombolysis; 2012 Nov; 34(4):446-56. PubMed ID: 22581282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of venous thromboembolism after surgery for esophagogastric malignancy and the impact of chemotherapy: a population-based cohort study.
    Adiamah A; Ban L; West J; Humes DJ
    Dis Esophagus; 2020 Jun; 33(6):. PubMed ID: 31617892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.